Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Plasma cell 1Dermatologic 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 16Myelodysplastic Syndromes 12Multiple Myeloma 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Hematologic Neoplasms 6Neuroblastoma 5Hodgkin Disease 5Retinoblastoma 4Lymphoma, Non-Hodgkin 4Graft vs Host Disease 4Anemia, Refractory, with Excess of Blasts 4Myeloproliferative Disorders 3Leukemia, Myelomonocytic, Chronic 3Recurrence 2Primary Myelofibrosis 2Myelodysplastic-Myeloproliferative Diseases 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Biphenotypic, Acute 2Leukemia, B-Cell 2Leukemia 2Ganglioneuroblastoma 2Anemia, Aplastic 2beta-Thalassemia 1Venentoclax 1Thrombocythemia, Essential 1Sarcoma, Ewing 1Rhabdomyosarcoma 1

Interventions

Cyclophosphamide 7acalabrutinib 4pirtobrutinib 3fludarabine 3Rituximab 3fludarabine phosphate 2Vincristine 2Melphalan 2Doxorubicin 2thymoglobulin 1obinutuzumab 1idecabtagene vicleucel 1ibrutinib 1Stem Cell Transplantation 1Prednisone 1Prednisolone 1Mycophenolic Acid 1Mesna 1Immunotherapy, Adoptive 1Filgrastim 1Diet 1Bone Marrow Transplantation 1ARQ531 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Leukemia, B-Cell × Melphalan × Clear all
NCT05589896 2026-02-24

A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies

Ossium Health, Inc.

Phase 1/2 Recruiting
12 enrolled
Classical hematologyDermatologicLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Hematologic Diseases, Hodgkin Disease, Leukemia, Lymphoma, Leukemia, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Cutaneous, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03852407 2022-10-12

HLA

University of Liege

Phase 2 Recruiting
114 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, B-Cell, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡